Oberdan Leo Group
Jelena joined the lab in January 2019. She obtained a grant from the Télévie and her work aims at the identification of regulatory pathways that oppose a therapeutic response to anti-PD1 treatment in murine tumor models.
Tamara obtained her PhD at the University of Oxford in 2018. She did a postdoc at the KU Leuven for a year before joining InhaTarget Therapeutics as Principal Scientist. InhaTarget is a ULB spin-off which successfully secured help from SPW Recherche with the FIRST enterprise docteur scheme. The immunobiology lab provides the ideal environment for this collaboration. Tamara investigates the mechanisms of actions between inhaled cisplatin and immune checkpoint inhibitors in lung cancer.
Isabelle provides administrative support to different team members of the laboratory.
02 650 98 61
Previous Lab Member
Yousra joined the immunobiology lab in 2016. She obtained a grant from the Télévie and her work is focused on the immune responses in the context oh hypoxia, with a particular interest in control of regulatory T cell activity by prolyl hydroxylase 2.
Isabel obtained her PhD in biomedical science at the KUL and joined the lab in 2016. She is working on characterizing (regulatory) T-cell heterogeneity during autoimmunity.